Skip to main content
Premium Trial:

Request an Annual Quote

Illinois to Use Genomics in Sorghum Biofuel Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Department of Agriculture has awarded a $1 million grant to the University of Illinois to use a range of genomics approaches to study if a gene system in sorghum could eventually be used and manipulated to increase biofuel production.

The research at the university will use comparative genomics, targeted resequencing, RNA expression analysis, and association mapping to characterize sorghum in order to regulate the maturation of shoots.

The studies will focus on the expression of a gene system called Glossy15, which in maize has been shown to be involved in delaying flowering and reducing grain yields while leading to increased accumulation of biomass and stalk sugars, as well as a decreased need for nitrogen.

"Because of the close relationship between maize and sorghum, it's possible that interactions between the genes in maize will help program differences in shoot maturation that distinguish grain, sweet, and biomass sorghum cultivars," Stephen Moose, a Univ. of Illinois professor of crop sciences and a member of the Energy Biosciences Institute in the Institute for Genomic Biology, said in a statement.

"Collectively, our results may lead to improved sorghum cultivars optimized for sustainable, low-cost production of biomass for lignocellulosic processing," he added.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more